Market Overview

Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Revenue Estimates

Related ALR
Proxy Statement Shows Danaher Faced Competition In Bid To Buy Cepheid
Benzinga's M&A Chatter for Friday August 26, 2016
Related ICLR
18 Biggest Mid-Day Gainers For Thursday
Stocks Hitting 52-Week Highs

Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year.

Analysts expect Alere (NYSE: ALR) to post revenue of $2.78 billion for the year ending December, 2012. Alere had $303.15 million in total cash for the latest quarter.

ICON Public Limited Company (NASDAQ: ICLR) is likely to post revenue of $1.10 billion in the year ending December, 2012. ICON's trailing-twelve-month operating margin is 5.29%.

Bio-Reference Laboratories (NASDAQ: BRLI) may report revenue of $651.40 million in the current year. Bio-Reference Laboratories' PEG ratio is 0.90.

Alliance Healthcare Services (NYSE: AIQ) is expected to report revenue of $487.02 million for the year ending December, 2012. Alliance Healthcare's trailing-twelve-month ROA is 4.51%.

Posted-In: Highest Revenue Estimates Medical Laboratories & Research Industry small-cap stocksTrading Ideas


Related Articles (AIQ + ALR)

View Comments and Join the Discussion!